Skip to main content

Aureomix S 40/40 Granular

This treatment applies to the following species:
Company: Zoetis

Caution: Federal law restricts medicated feed containing this veterinary feed directive (VFD) drug to use by or on the order of a licensed veterinarian.

Chlortetracycline, sulfamethazine

Type A Medicated Article

Active drug ingredients

Chlortetracycline calcium complex equivalent to chlortetracycline HCl

40 g/lb

Sulfamethazine

8.8% (40 g/lb)

Ingredients

Calcium sulfate and dried Streptomyces aureofaciens fermentation product.

For use in the manufacture of swine feeds

Aureomix S 40/40 Granular Indications

For reduction of the incidence of cervical abscesses; treatment of bacterial swine enteritis (salmonellosis or necrotic enteritis caused by Salmonella choleraesuis and vibrionic dysentery); prevention of these diseases during times of stress; and maintenance of weight gains in the presence of atrophic rhinitis.

Mixing Directions

Use 2.5 lb Aureomix® S 40/40 Granular per 1 ton (907.2 kg) of final feed. Make a preblend of 2.5 lb of Aureomix® S 40/40 Granular with part (15-20 lb) of the feed ingredients. Mix thoroughly with the remainder of the ingredients to give a final concentration of 100 g chlortetracycline and 100 g sulfamethazine per ton of feed.

Warning

Withdraw 15 days prior to slaughter

Store below 25°C (77°F), excursions permitted to 37°C (99°F).

Restricted Drug (California) - use only as directed. Not for human use.

Approved by FDA under NADA # 035-688

Distributed by: Zoetis Inc., Kalamazoo, MI 49007

Net wt

 

50 LB (22.68 kg)

40028662

CPN: 3690487.3

ZOETIS INC.
333 PORTAGE STREET, KALAMAZOO, MI, 49007
Telephone:   269-359-4414
Customer Service:   888-963-8471
Website:   www.zoetis.com
THIS SERVICE AND DATA ARE PROVIDED "AS IS". DVMetrics assumes no liability, and each user assumes full risk, responsibility, and liability, related to its use of the DVMetrics service and data. See the Terms of Use for further details.

Animalytix

Copyright © 2024 Animalytix LLC. Updated: 2024-02-27